Studies using cell lines and animal models have shown that MYC overexpression alone is not sufficient to induce cell transformation or tumor development; these events require the combined activity of MYC and at least one other oncogene (e.g., RAS) [13]. The gene discussed is MYC; the disease is neoplasm.